Methylation Predicts Outcome in Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
J. Clin. Oncol 2016 Nov 21;[EPub Ahead of Print], K Visvanathan, MS Fackler, Z Zhang, ZA Lopez-Bujanda, SC Jeter, LJ Sokoll, E Garrett-Mayer, LM Cope, CB Umbricht, DM Euhus, A Forero, AM Storniolo, R Nanda, NU Lin, LA Carey, JN Ingle, S Sukumar, AC WolffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.